Subject Matter Experts
Mark is a veteran SaaS revenue leader and has been leading revenue and sales teams and driving performance for the last 30 years in software and services companies. A results-oriented professional with a proven track record of delivering superior revenue results, Mark is passionate about scaling revenue organizations while helping customers to achieve their goals.
In his most recent role at MINDBODY, Mark held the role of Chief Revenue officer leading a global team that included the sales, services, and business development components of the business. Mark held senior roles at ADP, Citrix, Monster. Mark also helped SaaS startup organizations with their go to market strategy as part of his own consulting practice.
Mark received his BA in Business with an emphasis in marketing from Portland State University.
Outside of work, Mark enjoys the outdoors, running, biking, golfing, traveling and spending time with his wife and daughter where they reside in the Pacific Northwest.
Matt Brown is an accomplished agency leader and brand strategist, having spent the past two decades successfully building and launching dozens of healthcare brands for clients such as Genentech, Gilead, Johnson & Johnson, Merck and Zoetis. In addition to creating great brands for clients, Matt has spent the past 10 years building some of the industry’s leading agency brands. Most recently, Matt launched BrandMETTLE, an agency focused on bringing branding expertise and innovative technologies to brands engaging the 50+ consumer. Previously, Matt successfully created Guidemark Health by merging 5 independent healthcare agencies. While CEO of Guidemark Health, Matt served as interim CEO of Bluespire Marketing and Ariad Communications for about a year, which were both owned by the same private equity group as Guidemark Health.
Before Guidemark Health, Matt served as general manager of ICC Lowe. In addition to guiding the organizations transformation, Matt oversaw client relationships, new business activities, and worked closely with clients on the marketing of their products. Prior to ICC Lowe, Matt served as president of Ignite Health. During his tenure, the agency was nominated for Agency of the Year in recognition of significant growth and expansion. Matt served as senior vice president/managing director for GSW Worldwide prior to joining Ignite Health. During his 10 years at GSW, he held several positions with responsibility for leading account services, new business, staff development, as well as innovative business models and communications solutions for clients.
Matt is a graduate of The Ohio State University and served in the Army National Guard for 6 years before starting his professional career. Matt lives in Long Valley, New Jersey with his wife and 3 children.
Connect with Matt on Linkedin
Rod Cavin is an experienced and innovative leader with a background in market access strategy, brand planning, and organized customer sales and marketing. He has a proven track record of creating innovative solutions for clients to achieve growth.
He most recently led Health Strategies Group, a best-in-class US and EU market access research and consulting firm. Under his leadership the firm achieved significant growth and was sold to EVERSANA. In addition, he has held leadership roles in payer and IDN management as pharmacist leader and business development lead giving him a unique view of the needs of these customers.
Rod has worked with numerous pharmaceutical industry leaders to address the challenges of market access including new product entry planning, national account sales strategy, specialty product distribution, above brand customer planning, and health policy. He has extensive experience in emerging therapeutic areas including oncology, auto-immune, digital therapeutics, and rare disease.
Rod has a Bachelor’s of Pharmacy from the University of Iowa and MBA from the University of Illinois. He and his wife Kelly live in Newtown PA where they are active in their community.
Internationally recognized as a trusted advisor that accelerates business growth, Suzette possess a relentless drive to transform patient care, teamed with a keen ability to assess organizational opportunities, and assimilate ideas to drive financial success that align within a corporate culture. As an innovator, investor, thought leader, media contributor and sought after key note speaker/ educator on all things Specialty Pharmacy & Rare/Orphan Disease related; Suzette’s unique insight and savvy business advice continues to contribute to successful project executions and double digit revenue growth for Health Systems, Pharmaceutical/Biotech, Specialty Pharmacy and Private Equity/Venture Capital clients worldwide.
Suzette founded CSI Specialty Group In 2002, serving as President/CEO for 17 years. Under her leadership, honors include being named as one of Consulting Magazine’s Fastest Growing Firms, Goldman Sach’s Top Growing Businesses & recipient for an unprecedented 4 years in a row, of the coveted Commonwealth Institute’s Top 50 Women Led Business, from 2014-2018.
As a reflection of her dedication to the industry & servant leadership philosophy, Suzette received APPA’s Hall of Fame Award, honoring the ways she champions to improve patient care & access, as well as mentoring women through the Women in Specialty Pharmacy Organization she founded in 2013, and serving on the Executive team for the HBA Global Ambassador Program.
After a successful exit from CSI in 2019, Suzette seeks to guide innovative business models that have the opportunity to revolution and improve patient care outcomes, and may be seeking insight at the Board of Director, Advisory Board or Operating Partner level. She is also available for Consulting Projects and Subject Matter Expertise. A Proud West Point and Army mom, Suzette and her husband call Tampa, FL home.
George is an accomplished commercial leader within the life science industry and has extensive experience successfully leading the commercial sales, marketing and strategy efforts in emerging and established pharma and biotech companies. George is a veteran commercial leader with 25+ years of experience. For the past 9 years George has worked in the contract sales organization space helping emerging and established companies build and deploy sales and clinical educator teams as well as contact center solutions. George has worked with numerous pharmaceutical industry leaders to address the challenges they face launching products and expanding existing teams utilizing outsourced solutions.
Most recently George was employed at Ashfield Healthcare since April 2018 holding the title of President Global Business Development. Prior George held the position of General Manager US Commercial, while working at IQVIA Holdings. George also served as VP Global Business Development at Quintiles. George has held various sales and marketing positions with Roche, and Amgen leading the chronic kidney disease division. George began his career at GSK where he worked for 13 years.
Prior to joining Quintiles, George held sales leadership, training and marketing roles at various pharmaceutical companies, including 13 years with GlaxoSmithKline. George graduated with a bachelor’s degree in business administration from James Madison University in Harrisonburg, Va.
John P. Hall is a clinical development executive with 15+ years of industry experience. He began his career with a niche clinical research organization working through various operational departments before transitioning to the U.S. subsidiary of a Japanese pharmaceutical. He has been involved in all aspects of clinical trials from feasibility studies to archiving, Phase 1 (First in Human) to Phase 4 (Real World Evidence).
John started Shore Research & Development, LLC in 2012, a clinical operations consultancy focused on early clinical development. Shore R&D provides consultancy services for small to medium size biotechnology companies. Clients have been both private and public, primarily U.S. based but also included clients in South Korea and Belgium.
Over the past several years John has worked with clients to identify gaps in trial project management. John has successfully maximized the RFP process for trial services which has yielded costs savings and ensures vendor timeline accountability.
John is on the editorial board for Clinical Leader and on Gerson Lehrman Group Council of advisors. He received his BS from the University of Rhode Island and his MBA from Rider University. John is an avid runner and surfer and started Fund for 51 in 2011 to raise money for Duchenne Muscular Dystrophy.
John and his wife live in Spring Lake Heights, NJ and have 4 children.
Irene Infanti, R.N., MSN
Ms. Infanti is an independent healthcare consultant with a focus on the pharmaceutical industry. Her career has spanned over thirty years in the areas of drug safety, medical information, customer contact center management, and patient assistance program management. Ms. Infanti’s most recent position was Director, Medical Information Center for Janssen Pharmaceuticals, a member of the Johnson & Johnson Family of Companies. She has extensive experience in customer relationship management, development and oversight of non-profit foundations, contracting with customer facing service providers, and ensuring compliance with federal regulations.
Prior to joining Johnson & Johnson, Ms. Infanti practiced as a clinical registered nurse at Johns Hopkins Hospital. She earned a Master Degree in Nursing Administration and Management from LaSalle University and a Bachelor Degree in Nursing from Niagara University. Ms. Infanti also holds a US Healthcare Compliance Certificate from Seton Hall University.
MacKay Jimeson is an award winning public affairs and communications professional, a businessman and political adviser. As Managing Director of Ember Global Advisors, Jimeson helps position companies for growth in an evolving landscape of regulation, public opinion and disruptive competition. Previously, he led Corporate Affairs for Pfizer’s $9 billion Internal Medicine business. In that role he was responsible for public policy, government affairs, communications, advocacy and corporate responsibility for a portfolio of innovative medicines that prevent strokes, manage pain and treat tobacco addiction. Among Jimeson’s most notable accomplishments was his successful engagement strategy and message development that led to the unprecedented removal of an FDA Boxed Warning for the company’s smoking cessation medicine.
Previously, Jimeson was tapped by Pfizer’s Executive Vice President of Corporate Affairs, to serve as a special advisor where he developed an industry first digital grassroots initiative to support pro-medical innovation issues. He also served as Pfizer’s spokesperson and managed media relations. While in media relations he established strong relationships with global top-tier media, even earned praise from journalists themselves, and ultimately increasing the amount of favorable news coverage of Pfizer. Jimeson managed such complex company news as a spokesperson, such as the loss of exclusivity for the iconic cholesterol-lowering Lipitor when the patent expired.
Jimeson’s background in policy and public affairs were developed as an aide to Florida Governor Jeb Bush from 2001 to 2005. He served as a spokesman on education reform and recovery efforts after major hurricanes, wrote speeches and developed early digital campaigns. He was also an advisor on Senator John McCain’s 2008 presidential campaign.
Returning to his roots, Jimeson was active in Governor Bush’s 2016 presidential campaign, by serving as a policy advisor, on the national finance committee and by co-chairing Mission: NEXT, the largest Republican effort to engage millennial voters. He remains involved in politics and currently serves on the national finance committee for Texas Land Commissioner George P. Bush.
In 2016 PRWeek honored Jimeson by selecting him to their 40 under 40 list. The following year Maverick PAC, the premier national network for young conservative business professionals, named Jimeson to their list of the Future 40. In 2018 the American Council of Young Political Leaders, a program backed by the United States Department of State, selected Jimeson to serve on a seven person bipartisan delegation to Russia
Bill Lowe is a seasoned commercial leader with over 30 years of experience in Consumer Goods. He has a proven track record of success in business turnaround operations and is known for using his cross functional knowledge/skills to solve complex organizational challenges. Bill has direct experience in Field Sales, National Account Leadership, Headquarter Sales & Operations, Marketing, Marketing Operations, Strategic Planning, Demand Planning, IT Project Delivery, Process Reengineering, Post Merger Integration, and Acquisition Due Diligence.
Most recently Bill was the National Sales Head for the Equity Star Portfolio & the Head of Sales Operations for all Business Units at Bayer Consumer Health. Bill was successful in developing a new go-to-market strategy for the Equity Star business unit and was successful in reversing a 5-year decline in sales and was the only business unit in the Division to achieve its’ top and bottom line commitments. Additionally, he built across all Business Units a new Sales Operations platform out of disparate functions that dramatically increased customer satisfaction.
Bill’s prior assignment was Senior Vice President of Commercial and Marketing Operations at Bayer, a platform that he built from ground up to enable all Business Units for competitive advantage. Functions included HCP Marketing, Business Planning, Demand Planning, Market Research, Media Strategy & Buying, Consumer Engagement, Business Analytics, and Division Initiatives.
Bill graduated Summa Cum Laude with a master’s in business administration from the University of Texas at Dallas. Undergraduate degree is a Bachelor of Science in Operations Management from the University of Tennessee. Bill lives in Mendham, New Jersey with his wife, Lisa, and 3 children.
Bill O’Donnell is an accomplished strategic, operational and financial executive with more than three decades of experience.
Over the past several years Bill teamed with a Private Equity Group and built a progressive healthcare communication company through a series of strategic acquisitions and integration of healthcare advertising, PR and digital companies. The company was built to serve clients across the healthcare ecosystem to include payers, providers, healthcare tech as well as drug and device manufactures.
Previously, Bill was the President and COO of inVentiv Health Communications. With over 2,000 employees, Bill led one of the largest healthcare communications companies worldwide. inVentiv worked with global pharma, biotech, medical device and diagnostic companies. inVentiv brought industry leading advertising, PR, medical education, digital, and media together for integrated solutions to accelerate performance for client’s brands.
Bill began his career in the banking industry in both financial and operational roles at Bank One, now JP Morgan Chase. Over his career, Bill forged long lasting relationships between his organizations and his clients built on trust, transparency and the attainment mutual of goals.
Bill and his wife live in Columbus, OH and have 4 children.
Will Passano has extensive executive healthcare leadership expertise in the healthcare publishing / education sectors. With a foundation acquired from traditional publishing offerings that includes Williams & Wilkins, SCP Communications, and Jobson Healthcare Information, to more digital offerings like Skyscape, NetLearning and VOX Telehealth, he has been instrumental in growing these entities.
His strong and seasoned management skill set has provided guidance as several of these organizations were successfully sold during his leadership and he has a strong background in sales, internal operations, partner/lender and investor relations. With the rapidly changing landscape within the healthcare sector, Will has successfully adapted to capitalize on this dynamic shift.
Connect with Will on Linkedin
Ken Taylor is an accomplished agency executive with more than 25 years of success across the media, advertising and healthcare technology industries. Ken spent seven years as President at leading media agency, Starcom Worldwide. Most recently, Ken was a Managing Director at health tech start-up, Outcome Health.
Ken has partnered with numerous Fortune 500 companies as well as emerging brands to lead and transform their media practices. He has worked with the country’s largest and most successful marketers in developing media capabilities and building marketplace partnerships.
Through his extensive background in media, he has a depth of experience in areas critical to today’s marketers including media strategy, consumer behavior, digital transformation, data, analytics and investment stewardship.
Ken lives in Elmhurst, IL with his wife and two children.
Bob brings more than 25 years of life science strategic planning and product commercialization experience with both large and small pharma/biotech companies, and start-up environments. He is entrepreneurial and has an excellent grasp of business and economics, as well as current commercialization challenges. He has broad therapeutic area knowledge and a strong clinical background, with a particular expertise in oncology, as well as expertise in product strategy, launch planning, commercial operations, training, and business development.
Most recently, Bob has worked as a principal at BioSmarketing Solutions and as a consultant for Herspiegel Consulting, most often helping client organizations prepare for product launch. Bob has been a VP of Sales and Marketing for several companies, including Algos, Hexim and his own company DexGen Pharmaceuticals. At Genentech, he was instrumental in developing and implementing the PEL (Professional Education Liaison) and TLL (Thought Leader Liaison) programs. Bob has also been instrumental in developing and delivering best in class pharmaceutical sales and speaker training for several companies and products in several disease states, including oncology, at Amgen, The Liposome Company, Centocor, Algos, Genentech and Cyclacel.
Bob began his career as a sales representative for Upjohn and Amgen. He holds a Bachelor of Science degree in biology from the University of Connecticut and also studied at the University of Connecticut School of Dental Medicine.
Al is an accomplished sales and commercial operations leader with 37 years of experience in the pharmaceutical industry, including several years of service at the executive team level. His most recent corporate positions were SVP Market Access and Operations and VP Sales and Operations for Meda Pharmaceuticals. Al is recognized for building and leading highly productive teams in sales, training/organizational development, market access and analytics.
He is a strong communicator, decision maker and trusted colleague who has successfully taken on special assignments during difficult and unstable circumstances. In helping clients address the challenge of delivering results, Al draws upon his experience and focus on sales force effectiveness, building competency and hiring models, establishing performance management systems, and developing talent through coaching, mentoring.
Al also serves on the Board of Directors for the Mowat-Wilson Syndrome Foundation, where he is chairperson of the research committee. Mowat-Wilson Syndrome is a rare genetic disorder which his grandson was diagnosed with in 2010. He is a graduate of the University of Tennessee with a B.A. in biology.